James J. O'Mara
Amministratore Delegato presso Neurogastrx, Inc.
Profilo
James J.
O'Mara is the President & Chief Executive Officer at Neurogastrx, Inc. He previously worked as a Principal at Centocor, Inc. and Merck & Co., Inc. He also held positions as Vice President-Development at Ironwood Pharmaceuticals, Inc., Vice President at MPM BioImpact, Inc., and Vice President-Corporate Development at Cozint.
O'Mara received his undergraduate degree from Massachusetts College of Pharmacy & Health Science.
Posizioni attive di James J. O'Mara
| Società | Posizione | Inizio |
|---|---|---|
Neurogastrx, Inc.
 Neurogastrx, Inc. BiotechnologyHealth Technology Neurogastrx, Inc. operates as a venture-stage biopharmaceutical company. The firm develops biopharmaceutical products for the treatment of gastrointestinal disorders. It offers NG101, a product for the treatment of gastroparesis. The company was founded by Cyril De Colle and Pankaj Jay Pasricha and is headquartered in Campbell, CA. | Amministratore Delegato | 01/10/2017 |
Precedenti posizioni note di James J. O'Mara
| Società | Posizione | Fine |
|---|---|---|
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Corporate Officer/Principal | - |
Cozint
 Cozint Internet Software/ServicesTechnology Services Part of Informa Plc, Cozint is a company that provides web-based research solutions to the pharmaceutical and biotechnology industries. The company is based in Andover, MA. The company was founded by Harris Kaplan. Cozint was acquired by UBMG Holdings from ZS Associates, Inc. on January 08, 2002 for $10.50 million. | Corporate Officer/Principal | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Corporate Officer/Principal | - |
| IRONWOOD PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formazione di James J. O'Mara
| Massachusetts College of Pharmacy & Health Science | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Health Technology |
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Finance |
Cozint
Cozint Internet Software/ServicesTechnology Services Part of Informa Plc, Cozint is a company that provides web-based research solutions to the pharmaceutical and biotechnology industries. The company is based in Andover, MA. The company was founded by Harris Kaplan. Cozint was acquired by UBMG Holdings from ZS Associates, Inc. on January 08, 2002 for $10.50 million. | Technology Services |
Neurogastrx, Inc.
Neurogastrx, Inc. BiotechnologyHealth Technology Neurogastrx, Inc. operates as a venture-stage biopharmaceutical company. The firm develops biopharmaceutical products for the treatment of gastrointestinal disorders. It offers NG101, a product for the treatment of gastroparesis. The company was founded by Cyril De Colle and Pankaj Jay Pasricha and is headquartered in Campbell, CA. | Health Technology |
- Borsa valori
- Insiders
- James J. O'Mara
